English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
Add to Basket
  Local TagsRelease HistoryDetailsSummary

Released
Journal Article

Spironolactone is an antagonist of NRG1-ERBB4 signaling and schizophrenia-relevant endophenotypes in mice

MPS-Authors
/persons/resource/persons182199

Hinrichs,  Wilko
Gene expression and signaling, Neurogenetics, Max Planck Institute of Experimental Medicine, Max Planck Society;

/persons/resource/persons182462

Unterbarnscheidt,  Tilmann
Neurogenetics, Max Planck Institute of Experimental Medicine, Max Planck Society;

/persons/resource/persons207307

Soto-Bernardini,  Maria Clara
Neurogenetics, Max Planck Institute of Experimental Medicine, Max Planck Society;

/persons/resource/persons182320

Nave,  Klaus-Armin
Neurogenetics, Max Planck Institute of Experimental Medicine, Max Planck Society;

/persons/resource/persons182402

Schwab,  Markus H.
Neurogenetics, Max Planck Institute of Experimental Medicine, Max Planck Society;

/persons/resource/persons182378

Rossner,  Moritz J.
Neurogenetics, Max Planck Institute of Experimental Medicine, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)

Wehr_17.pdf
(Publisher version), 936KB

Supplementary Material (public)
There is no public supplementary material available
Citation

Wehr, M. C., Hinrichs, W., Brzózka, M. M., Unterbarnscheidt, T., Herholt, A., Wintgens, J. P., et al. (2017). Spironolactone is an antagonist of NRG1-ERBB4 signaling and schizophrenia-relevant endophenotypes in mice. Embo Molecular Medicine, 9(10), 1448-1462. doi:10.15252/emmm.201707691.


Cite as: https://hdl.handle.net/11858/00-001M-0000-002D-C476-7
Abstract
There is no abstract available